Clinical Trial Update: Efficacy and Safety of PL9643 Ophthalmic Solution in Subjects With Dry Eye [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the efficacy and safety of PL9643 ophthalmic solution in subjects with Dry Eye Disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• PL9643

Snippet

Sponsor: ORA, Inc. | Conditions: Dry Eye Disease | Phase 2 | Status: COMPLETED